Julie Redfern is Deputy Director, Cardiovascular Division at The George Institute for Global Health, an Associate Professor in the Faculty of Medicine at the University of Sydney and a practising Physiotherapist.  

Julie is an advocate for effective secondary prevention of cardiovascular disease and her research interest is focused on improving clinical practice and reduction of risk factors ultimately in people with a range of chronic diseases.  A/Professor Redfern holds a NHMRC Career Development and Heart Foundation Future Leader Fellowship. She was recently selected on the World Heart Federation Emerging Leader Program and concluded a 6 year term on the CSANZ Board and as Chair of the Allied Health Council.

She is currently the Co-Chair of the Clinical and Preventative Cardiology Council of the Cardiac Society of Australia and New Zealand, Co-Chair of the National Secondary Prevention Alliance and part of the team that won the 2016 Australian Google Impact Challenge. Julie’s research aims to improve access to and engagement with secondary prevention strategies with a focus on technology.

Professor Berwanger leads the Institute’s work in the UK in partnership with Imperial College London, with a core focus on health systems science, multimorbidity, women’s health, large-scale clinical trials and planetary health. He is also building on his personal research interests in exploring innovative clinical trial models, as well as the conduct of efficient implementation science studies.

Prior to joining The George Institute, he was Director of the Academic Research Organisation (ARO) of the Albert Einstein Israelite Hospital in São Paulo, Brazil. An esteemed cardiologist and clinical trialist, Professor Berwanger has extensive research and managerial experience and has led large-scale, randomised clinical trials nationally and internationally across many countries including Brazil, Australia, New Zealand, Canada, China, Chile, Argentina, Peru and Colombia. Trials led by him have been published in high-impact journals such as the New England Journal of Medicine, The Lancet, JAMA and the BMJ.

Dorrilyn Rajbhandari is a Senior Project Manager at the George Institute for Global Health. She is chair of the Project Manager Interest Group, and a member of the ANZICS Clinical Trial Group. As a Senior Project Manager, with many years of experience as a nurse clinician in intensive care research, she has vast experience in clinical trial management, operationalisation of protocols, including protocol development and design, CRF design, website and data management, multiple sub-studies, final analysis and resulting publications. She is a resource and mentor for colleagues.

Dorrilyn has successfully coordinated and managed many multi-centre, worldwide clinical trials in intensive care. She has successfully completed, within expected timelines, the CHEST study (7000 patients), ADRENAL study, a 3,800 patient study from 70 sites worldwide, including the ADRENAL-GEPS Sub-Study, with the largest severe sepsis cohort in precision medicine. The process provided experience in drug manufacture, regulatory requirements and regulatory approvals in multiple countries including importation and exportation processes and requirements, sample collections and transfers from around the world. Dorrilyn is currently project managing a number of studies; BLING III multicentre clinical outcome study, a 7000 patient study from 100 sites around the world. FluDReSS, a 300 patient study from 10 sites. HOPE, hydroxycholoquine prophylaxis in health care workers in India. 

Dorrilyn Rajbhandari has the expertise to implement, manage and complete efficiently within timelines, large multi-centre clinical trials with results published in high quality journals.

Bianca Barnier identifies as a Gumbaynggir woman and is a Project Manager within the Guunu-maana (Heal) Aboriginal and Torres Strait Islander Health Program. Bianca has extensive experience in project management, reporting and finance, as well as community engagement.

Bianca coordinates and monitors projects from start to completion and is committed to ensuring that all projects developed with Aboriginal and Torres Strait Islander people are underpinned by equity, transparency and self-determination. Bianca is a proud mother of two and an active member of her community.

Dr Mae Lim is a Research Fellow at The George Institute and a Conjoint Associate Lecturer at the University of New South Wales. She is also a Postdoctoral Fellow at Neuroscience Research Australia.

Her research promotes adaptive ageing and empowers older people to stay independent in the community. More specifically, she currently leads a research program on applying the health literacy lens to preventing falls and reducing concerns about falling in older people. She developed the novel Falls Health Literacy Scale which enabled clinicians to quantify a person's health literacy in the context of fall prevention. 

Dr Lim is also passionate about investigating the potential benefits of intergenerational practice in preventing frailty and falls in older people. Currently, she is the leading Research Fellow working on the NHMRC-funded large multi-site clinical trial to test the impact of intergenerational practice on improving the physical, cognitive, and psychological outcomes in older people.